1995 outlook: research strategy. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


1995 outlook: research strategy. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Treat News. 1995 Jan 20;(No 215):5-7. Unique Identifier : AIDSLINE AIDS/95700106
James JS

Abstract: There are more opportunities for progress toward improvement in AIDS/HIV treatment. The tools for research are better; there are safe, rapid, low-cost, high-quality treatment trials; and there are more cases of improvement in people with HIV or AIDS. However, no one knows how long the improvements will last. Success stories should be seen as treatment leads for further research. The author proposes research strategies: such as using small, rapid screening trials as a way to prove clinical benefit, and using new, unknown mechanisms of action. Treatments which seem to be helping in some way, but which have no known mechanism of action, should be researched to discover how they work. National commitment to AIDS also affects research. A social movement needs to be established so that people can support AIDS funding and create progress in treating AIDS.
Keywords: Acquired Immunodeficiency Syndrome/*THERAPY Clinical Trials/*METHODS Health Policy Human HIV Infections/*THERAPY Public Opinion *Research Design Research Support United States NEWSLETTER ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDtherapyclinicaltrials/KWDmethodshealthpolicyhumanhivinfections/KWDtherapypublicopinionKWDresearchdesignresearchsupportunitedstatesnewsletterarticle
950530
M9551027

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .